NCT04573231 2026-02-05
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
University of Wisconsin, Madison
Phase 2 Recruiting
Clinical Trials
1 trialsBreast Neoplasms × 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid × Clear all